跳至主要内容
临床试验/NCT02580929
NCT02580929Unknown不适用

Effectiveness of Radiotherapy Before Surgery in Patients With High-risk Relapse Hepatocellular Carcinoma

Peking Union Medical College1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
mortality

研究概览

简要总结

This study aims to evaluate the effectiveness of radiotherapy before surgery in high-risk relapse hepatocellular cancer patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of HCC
  • In high risk of recurrence of HCC but still can endure palliative resection
  • KPS scores are >90
  • With Child-Pugh Class A liver funcion, serum bilirubin< 1.5*normal maxism; ALT and AST< 1.5*normal maxism; normal creatinine and urea nitrogen; WBC>4×109/L, Hb>110g/L, PLT>90X109/L.
  • Have signed informed consent

排除标准

  • HCC cannot be operated
  • With Child-Pugh Class B/C
  • Have other organ cancer, excluding curative non-melanotic skin cancer and carcinoma in situ of cervix
  • Have other severe disease
  • With active hepatitis
  • Have accepted local radiation therapy in other hospitals
  • KPS scores≤70
  • Tumor edges cannot be defined
  • Have severe cirrhosis complication
  • Intensity modulated radiation therapy cannot reach required dose
  • Cannot cooperate
  • Lactant or pregnant
  • Cannnot be informed

结局指标

主要结局

mortality

时间窗: 5 years

次要结局

未报告次要终点

研究者

发起方
Peking Union Medical College
申办方类型
Other
责任方
Principal Investigator
主要研究者

WU FAN

Doctor

Peking Union Medical College

研究点 (1)

Loading locations...

相似试验

Clinical Study of Effectiveness of Radiotherapy... | 临床试验